Spots Global Cancer Trial Database for Asciminib Roll-over Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Asciminib Roll-over Study
Official Title: An Open Label, Multi-center Asciminib Roll-over Study to Assess Long-term Safety in Patients Who Have Completed a Novartis Sponsored Asciminib Study and Are Judged by the Investigator to Benefit From Continued Treatment
Study ID: NCT04877522
Study Description
Brief Summary: This is a long term safety study for patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment
Detailed Description: This is an open-label, multi-center, global roll-over study designed to assess long term safety and provide continued treatment to participants who have previously participated in an asciminib Novartis sponsored study and who, in the opinion of the investigator, would benefit from continued treatment as in the parent study, or from switching to asciminib (if they were on bosutinib in the parent study), but are unable to access this treatment outside of the clinical study.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Michigan Med University of Michigan ., Ann Arbor, Michigan, United States
Memorial Sloan Kettering, New York, New York, United States
Oregon Health Sciences University ., Portland, Oregon, United States
Uni of TX MD Anderson Cancer Cntr, Houston, Texas, United States
Novartis Investigative Site, Caba, Buenos Aires, Argentina
Novartis Investigative Site, Wien, , Austria
Novartis Investigative Site, Rio de Janeiro, RJ, Brazil
Novartis Investigative Site, Sao Paulo, SP, Brazil
Novartis Investigative Site, Sao Paulo, SP, Brazil
Novartis Investigative Site, Varna, , Bulgaria
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Ostrava, Poruba, Czechia
Novartis Investigative Site, Brno-Bohunice, , Czechia
Novartis Investigative Site, Copenhagen, , Denmark
Novartis Investigative Site, Bordeaux, , France
Novartis Investigative Site, Marseille, , France
Novartis Investigative Site, Paris 10, , France
Novartis Investigative Site, Vandoeuvre les Nancy, , France
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Frankfurt, , Germany
Novartis Investigative Site, Jena, , Germany
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Napoli, , Italy
Novartis Investigative Site, Kobe-shi, Hyogo, Japan
Novartis Investigative Site, Uijeongbu si, Gyeonggi Do, Korea, Republic of
Novartis Investigative Site, Busan, , Korea, Republic of
Novartis Investigative Site, Jeollanam, , Korea, Republic of
Novartis Investigative Site, Beirut, , Lebanon
Novartis Investigative Site, Monterrey, Nuevo Leon, Mexico
Novartis Investigative Site, Krakow, , Poland
Novartis Investigative Site, Warszawa, , Poland
Novartis Investigative Site, Wroclaw, , Poland
Novartis Investigative Site, Lisboa, , Portugal
Novartis Investigative Site, Porto, , Portugal
Novartis Investigative Site, Timisoara, , Romania
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Saint Petersburg, , Russian Federation
Novartis Investigative Site, St Petersburg, , Russian Federation
Novartis Investigative Site, Riyadh, , Saudi Arabia
Novartis Investigative Site, Singapore, , Singapore
Novartis Investigative Site, Sevilla, Andalucia, Spain
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Hospitalet de LLobregat, Catalunya, Spain
Novartis Investigative Site, Bilbao, Pais Vasco, Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Valencia, , Spain
Novartis Investigative Site, Taoyuan, , Taiwan
Novartis Investigative Site, Samsun, , Turkey
Novartis Investigative Site, Oxford, , United Kingdom
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
